IKKε deficiency reduces osteoarthritis pain and synovitis in mice

Researchers using cultured cells and two complementary mouse models found that loss of IκB kinase epsilon (IKKε) reduced osteoarthritis-associated pain-related behavior and synovitis, but did not yield a statistically significant reduction in cartilage degeneration. The findings distinguish IKKε deficiency’s apparent effects on symptoms and joint inflammation from its uncertain effect on structural cartilage damage.

Osteoarthritis is a whole-joint disease characterized in the study by cartilage degeneration, synovial inflammation and chronic pain. The researchers examined whether IKKε contributes differently to these disease components through in vitro analyses of primary chondrocytes and synovial cells, together with in vivo experiments in IKKε-deficient mice. The animal work used the MIA model to assess pain and synovitis and a model combining DMM and MCLT to examine cartilage degeneration and molecular changes.

In primary chondrocytes, IKKε deficiency reduced c-Jun phosphorylation and decreased expression of Mmp13, a gene associated with cartilage catabolism. In synovial cells, it also lowered expression of the chemokine Ccl2. Phosphorylation of p65, another measured signaling output, did not differ significantly between genotypes. These cell experiments indicate that removing IKKε changes selected inflammatory and catabolic signals rather than producing the same response across every pathway examined.

The mouse experiments produced a similar separation between behavioral or inflammatory outcomes and cartilage structure. In the MIA model, IKKε-deficient mice had attenuated synovitis and less mechanical hypersensitivity, which the researchers interpreted as reduced osteoarthritis-associated pain-related behavior. In the DMM + MCLT model, inflammatory and catabolic markers in cartilage were reduced. However, histological assessment detected no statistically significant reduction in cartilage degeneration. IKKε-deficient chondrocytes also expressed higher levels of Ikkβ and Tbk1, suggesting a possible adaptive response, although the study did not establish whether these changes functionally compensated for the missing kinase.

Overall, the results support IKKε as a potential target for osteoarthritis pain and synovial pathology, while leaving its influence on structural cartilage preservation uncertain. The evidence comes from cultured cells and mouse models, so it does not show that modifying IKKε would reduce pain or protect cartilage in people with osteoarthritis. Any assessment of the pathway’s therapeutic value would require further evidence beyond these experiments.

Subject of Research: Effects of IKKε deficiency on osteoarthritis pain, synovitis and cartilage degeneration in mouse models

Article Title: IκB kinase epsilon deficiency attenuates osteoarthritis-associated pain and synovitis with limited cartilage protection in complementary mouse models

Article References: Sakai, M., Akasaki, Y., Hyodo, Y., Kurakazu, I., Uchida, T., Hirose, R., Kuwahara, M., Kita, T., Kato, K., Ziyang, L., Eto, G., & Nakashima, Y. (2026). IκB kinase epsilon deficiency attenuates osteoarthritis-associated pain and synovitis with limited cartilage protection in complementary mouse models. Scientific Reports. https://doi.org/10.1038/s41598-026-76585-8

Image Credits: AI Generated

DOI: 10.1038/s41598-026-76585-8

Keywords: IKK epsilon, osteoarthritis, joint pain, synovitis, cartilage degeneration, mouse models, chondrocytes, inflammation, MMP13, CCL2, kinase, epsilon